Skip to Content

APO MYC500 (Mycophenolate Mofetil 500 mg)

Pill with imprint APO MYC500 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Apotex Corp..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO MYC500

Mycophenolate Mofetil

Imprint
APO MYC500
Strength
500 mg
Color
Purple
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
Inactive Ingredients
croscarmellose sodium, magnesium stearate, ferric oxide red, titanium dioxide, ferrosoferric oxide, microcrystalline cellulose, silicon dioxide, hypromelloses, hydroxypropyl cellulose (type h), propylene glycol

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
60505-2967 Apotex Corp.
68084-0588 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.